Monday, June 15, 2026

A 90-Minute Cancer Infusion Could Soon Be Cut to 5 Minutes—and Celltrion Wants to Lead It

Celltrion has applied for EMA approval of Herzuma SC, a new breast cancer treatment, enhancing drug delivery and patient convenience.

Discover Pyongyang’s New Beer Paradise on Rimhung Street!

North Korean state-run media outlets have recently...

How Daewoong, Naver, and J&P Medi are Transforming Digital Health: Key Insights from the 2026 Partners Day

The event showcases 10 startups presenting innovations in digital healthcare, focusing on AI, brain health, and business strategies.

Tag: magazine

North Korea Korea Kim Military AI South Korea market relations International

No posts to display

Top News

Celltrion’s ‘Psoriasis’ Biosimilar Poised to Challenge Big Pharma with Phase 1...

Do Min Jang - September 23, 2025

The EADV conference in Paris showcased Celltrion's biosimilar CT-P55, confirming its equivalence to Cosentyx in safety and pharmacokinetics.

Biosimilars No Longer Second-Best: Highlighting Cost Savings and Improved Patient Access

September 22, 2025

Salmonella Outbreak Linked to Superfoods: What You Need to Know About...

January 26, 2026

Did North Korea Really Want to Ditch Its Nukes? Insights from...

September 3, 2025

Global Markets Crash—Who Is the Major Loser Here?

April 22, 2025

CAPITALIST INSURGENCY: Chanel Lipstick Is Now A Symbol Of Defiance Against...

November 25, 2025

Over Half of Top Propofol-Using Clinics in Asia Found Violating Drug...

April 8, 2026

South Korean Court Sentences Gambling Site Operator for Collaboration With North...

May 26, 2026

- Our Sponsors Ad -

Follow us